E2f2 induces cone photoreceptor apoptosis independent of E2f1 and E2f3

Cell Death and Differentiation

Volumn 20, Issue 7, 2013, Pages 931-940

  Chen, D ^a,b,c   Chen, Y ^a,b   Forrest, D ^d   Bremner, R ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c Ophthalmic Laboratory of Molecular Medicine Research Center   (China)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Cone photoreceptor; E2f; p53; Retina

Indexed keywords

PROTEIN P107; PROTEIN P53; PROTEIN P73; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR E2F2; TRANSCRIPTION FACTOR E2F3;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; GANGLION; IN VIVO STUDY; MOUSE; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; RETINA CONE; RETINA NERVE CELL; RETINOBLASTOMA; UPREGULATION;

ANIMALS; APOPTOSIS; CELL DIVISION; DNA-BINDING PROTEINS; E2F1 TRANSCRIPTION FACTOR; E2F2 TRANSCRIPTION FACTOR; E2F3 TRANSCRIPTION FACTOR; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, ANIMAL; NUCLEAR PROTEINS; RETINA; RETINAL CONE PHOTORECEPTOR CELLS; RETINOBLASTOMA PROTEIN; RETINOBLASTOMA-LIKE PROTEIN P107; TUMOR SUPPRESSOR PROTEINS;

EID: 84880274644     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2013.24     Document Type: Article

References (60)

1. Pacal M, Bremner R. Insights from animal models on the origins and progression of retinoblastoma. Curr Mol Med 2006; 6: 759-781.
2. DeGregori J, Johnson DG. Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis. Curr Mol Med 2006; 6: 739-748.
3. Trimarchi JM, Lees JA. Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol 2002; 3: 11-20.
4. Chen HZ, Tsai SY, Leone G. Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat Rev Cancer 2009; 9: 785-797.
5. Tsai SY, Opavsky R, Sharma N, Wu L, Naidu S, Nolan E et al. Mouse development with a single E2F activator. Nature 2008; 454: 1137-1141.
6. Wu X, Levine AJ. p53 and E2F-1 cooperate to mediate apoptosis. Proc Natl Acad Sci USA 1994; 91: 3602-3606.
7. Kowalik TF, DeGregori J, Schwarz JK, Nevins Jr. E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J Virol 1995; 69: 2491-2500.
8. Qin XQ, Livingston DM, Kaelin WG Jr., Adams PD. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc Natl Acad Sci USA 1994; 91: 10918-10922.
9. DeGregori J, Leone G, Miron A, Jakoi L, Nevins Jr. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc Natl Acad Sci USA 1997; 94: 7245-7250.
10. Vigo E, Muller H, Prosperini E, Hateboer G, Cartwright P, Moroni MC et al. CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase. Mol Cell Biol 1999; 19: 6379-6395.
11. Moroni MC, Hickman ES, Denchi EL, Caprara G, Colli E, Cecconi F et al. Apaf-1 is a transcriptional target for E2F and p53. Nat Cell Biol 2001; 3: 552-558.
12. Pierce AM, Gimenez-Conti IB, Schneider-Broussard R, Martinez LA, Conti CJ, Johnson DG. Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53. Proc Natl Acad Sci USA 1998; 95: 8858-8863.
13. Paulson QX, McArthur MJ, Johnson DG. E2F3a stimulates proliferation, p53-independent apoptosis and carcinogenesis in a transgenic mouse model. Cell Cycle 2006; 5: 184-190.
14. Chen Q, Hung FC, Fromm L, Overbeek PA. Induction of cell cycle entry and cell death in postmitotic lens fiber cells by overexpression of E2F1 or E2F2. Invest Ophthalmol Vis Sci 2000; 41: 4223-4231.
15. Chen Q, Liang D, Yang T, Leone G, Overbeek PA. Distinct capacities of individual E2Fs to induce cell cycle re-entry in postmitotic lens fiber cells of transgenic mice. Dev Neurosci 2004; 26: 435-445.
16. Ebelt H, Hufnagel N, Neuhaus P, Neuhaus H, Gajawada P, Simm A et al. Divergent siblings: E2F2 and E2F4 but not E2F1 and E2F3 induce DNA synthesis in cardiomyocytes without activation of apoptosis. Circ Res 2005; 96: 509-517.
17. Denchi EL, Helin K. E2F1 is crucial for E2F-dependent apoptosis. EMBO Rep 2005; 6: 661-668.
18. Tsai KY, Hu Y, Macleod KF, Crowley D, Yamasaki L, Jacks T. Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. Mol Cell 1998; 2: 293-304.
19. Ziebold U, Reza T, Caron A, Lees JA. E2F3 contributes both to the inappropriate proliferation and to the apoptosis arising in Rb mutant embryos. Genes Dev 2001; 15: 386-391.
20. Saavedra HI, Wu L, de Bruin A, Timmers C, Rosol TJ, Weinstein M et al. Specificity of E2F1, E2F2, and E2F3 in mediating phenotypes induced by loss of Rb. Cell Growth Differ 2002; 13: 215-225.
21. Wu L, De Bruin A, Saavedra HI, Starovic M, Trimboli A, Yang Y et al. Extra-embryonic function of Rb is essential for embryonic development and viability. Nature 2003; 421: 942-947.
22. Robanus-Maandag EC, Van der Valk M, Vlaar M, Feltkamp C, O'Brien J, Van Roon M et al. Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice. EMBO J 1994; 13: 4260-4268.
23. Chen D, Livne-Bar I, Vanderluit JL, Slack RS, Agochiya M, Bremner R. Cell-specific effects of RB or RB/p107 loss on retinal development implicate an intrinsically death-resistant cell-of-origin in retinoblastoma. Cancer Cell 2004; 5: 539-551.
24. MacPherson D, Sage J, Kim T, Ho D, McLaughlin ME, Jacks T. Cell type-specific effects of Rb deletion in the murine retina. Genes Dev 2004; 18: 1681-1694.
25. Chen D, Opavsky R, Pacal M, Tanimoto N, Wenzel P, Seeliger MW et al. Rb-mediated neuronal differentiation through cell-cycle-independent regulation of E2f3a. PLoS Biol 2007; 5: e179.
26. McClellan KA, Ruzhynsky VA, Douda DN, Vanderluit JL, Ferguson KL, Chen D et al. Unique requirement for Rb/E2F3 in neuronal migration: evidence for cell cycle-independent functions. Mol Cell Biol 2007; 27: 4825-4843.
27. Jiang Z, Liang P, Leng R, Guo Z, Liu Y, Liu X et al. E2F1 and p53 are dispensable, whereas p21(Waf1/Cip1) cooperates with Rb to restrict endoreduplication and apoptosis during skeletal myogenesis. Dev Biol 2000; 227: 28-41.
28. Liu Y, Zacksenhaus E. E2F1 mediates ectopic proliferation and stage-specific p53- dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses. Oncogene 2000; 19: 6065-6073.
29. Field SJ, Tsai FY, Kuo F, Zubiaga AM, Kaelin WG Jr, Livingston DM et al. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 1996; 85: 549-561.
30. Biswas AK, Johnson DG. Transcriptional and nontranscriptional functions of E2F1 in response to DNA damage. Cancer Res 2012; 72: 13-17.
31. Martinez LA, Goluszko E, Chen HZ, Leone G, Post S, Lozano G et al. E2F3 is a mediator of DNA damage-induced apoptosis. Mol Cell Biol 2010; 30: 524-536.
32. Hallstrom TC, Nevins Jr. Jab1 is a specificity factor for E2F1-induced apoptosis. Genes Dev 2006; 20: 613-623.
33. Dick FA, Dyson N. pRB contains an E2F1-specific binding domain that allows E2F1- induced apoptosis to be regulated separately from other E2F activities. Mol Cell 2003; 12: 639-649.
34. Opavsky R, Tsai SY, Guimond M, Arora A, Opavska J, Becknell B et al. Specific tumor suppressor function for E2F2 in Myc-induced T-cell lymphomagenesis. Proc Natl Acad Sci USA 2007; 104: 15400-15405.
35. Rogoff HA, Pickering MT, Frame FM, Debatis ME, Sanchez Y, Jones S et al. Apoptosis associated with deregulated E2F activity is dependent on E2F1 and Atm/Nbs1/Chk2. Mol Cell Biol 2004; 24: 2968-2977.
36. Fogal V, Kartasheva NN, Trigiante G, Llanos S, Yap D, Vousden KH et al. ASPP1 and ASPP2 are new transcriptional targets of E2F. Cell Death Differ 2005; 12: 369-376.
37. Sangwan M, McCurdy SR, Livne-Bar I, Ahmad M, Wrana JL, Chen D et al. Established and new mouse models reveal E2f1 and Cdk2 dependency of retinoblastoma, and expose effective strategies to block tumor initiation. Oncogene 2012; 31: 5019-5028.
38. Chen D, Pacal M, Wenzel PL, Knoepfler PS, Leone G, Bremner R. Division and apoptosis of E2f-deficient retinal progenitors. Nature 2009; 462: 925.
39. Ng L, Hurley JB, Dierks B, Srinivas M, Salto C, Vennstrom B et al. A thyroid hormone receptor that is required for the development of green cone photoreceptors. Nat Genet 2001; 27: 94-98.
40. Wright AF, Chakarova CF, Abd El-Aziz MM, Bhattacharya SS. Photoreceptor degeneration: genetic and mechanistic dissection of a complex trait. Nat Rev Genet 2010; 11: 273-284.
41. Bates S, Phillips AC, Clark PA, Stott F, Peters G, Ludwig RL et al. p14ARF links the tumour suppressors RB and p53. Nature 1998; 395: 124-125.
42. Chen D, Shan J, Zhu WG, Qin J, Gu W. Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses. Nature 2010; 464: 624-627.
43. Chio II, Sasaki M, Ghazarian D, Moreno J, Done S, Ueda T et al. TRADD contributes to tumour suppression by regulating ULF-dependent p19Arf ubiquitylation. Nat Cell Biol 2012; 14: 625-633.
44. Yang A, Walker N, Bronson R, Kaghad M, Oosterwegel M, Bonnin J et al. p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 2000; 404: 99-103.
45. Marino S, Vooijs M, van Der Gulden H, Jonkers J, Berns A. Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. Genes Dev 2000; 14: 994-1004.
46. Phillips AC, Ernst MK, Bates S, Rice NR, Vousden KH. E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways. Mol Cell 1999; 4: 771-781.
47. Bremner R. Retinoblastoma, an inside job. Cell 2009; 137: 992-994.
48. Xu XL, Fang Y, Lee TC, Forrest D, Gregory-Evans C, Almeida D et al. Retinoblastoma has properties of a cone precursor tumor and depends upon cone-specific MDM2 signaling. Cell 2009; 137: 1018-1031.
49. Corson TW, Gallie BL. One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma. Genes Chromosomes Cancer 2007; 46: 617-634.
50. Elison JR, Cobrinik D, Claros N, Abramson DH, Lee TC. Small molecule inhibition of HDM2 leads to p53-mediated cell death in retinoblastoma cells. Arch Ophthalmol 2006; 124: 1269-1275.
51. Laurie NA, Donovan SL, Shih CS, Zhang J, Mills N, Fuller C et al. Inactivation of the p53 pathway in retinoblastoma. Nature 2006; 444: 61-66.
52. Conkrite K, Sundby M, Mu D, Mukai S, MacPherson D. Cooperation between Rb and Arf in suppressing mouse retinoblastoma. J Clin Invest 2012; 122: 1726-1733.
53. Herrup K, Yang Y. Cell cycle regulation in the postmitotic neuron: oxymoron or new biology? Nat Rev Neurosci 2007; 8: 368-378.
54. Wu J, Trogadis J, Bremner R. Rod and cone degeneration in the rd mouse is p53 independent. Mol Vis 2001; 7: 101-106.
55. Marquardt T, Ashery-Padan R, Andrejewski N, Scardigli R, Guillemot F, Gruss P. Pax6 is required for the multipotent state of retinal progenitor cells. Cell 2001; 105: 43-55.
56. Vooijs M, Berns A. Developmental defects and tumor predisposition in Rb mutant mice. Oncogene 1999; 18: 5293-5303.
57. LeCouter JE, Kablar B, Hardy WR, Ying C, Megeney LA, May LL et al. Strain-dependent myeloid hyperplasia, growth deficiency, and accelerated cell cycle in mice lacking the Rbrelated p107 gene. Mol Cell Biol 1998; 18: 7455-7465.
58. Leone G, Sears R, Huang E, Rempel R, Nuckolls F, Park CH et al. Myc requires distinct E2F activities to induce S phase and apoptosis. Mol Cell 2001; 8: 105-113.
59. Wu L, Timmers C, Maiti B, Saavedra HI, Sang L, Chong GT et al. The E2F1-3 transcription factors are essential for cellular proliferation. Nature 2001; 414: 457-462.
60. Jonkers J, Meuwissen R, van der Gulden H, Peterse H, van der Valk M, Berns A. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat Genet 2001; 29: 418-425.